Cravacin (Deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Age
24
Location
Everest Pharmaceuticals Limited– Rahman’s Regnum Centre (10th & 11th Floor) 191/1, Bir Uttam Mir Shawkat Sarak Tejgaon C/A,Dhaka-1208, Bangladesh